Speaker illustration

Doctor Kostiantyn Yushko

L.T.Malaya Therapy National Institute of the National Academy of Medical Sciences of Ukraine, Kharkiv (Ukraine)

Member of:

EAPCI
Heart Failure Association

The scientist researcher in the Department of Arterial Hypertension and Prevention of Its Complications of "L.T.Malaya Therapy National Institute of NAMS of Ukraine", Kharkiv, Ukraine. The scientist interests are - arterial hypertension, atrial fibrillation, heart failure, obesity, type 2 diabetes, atherosclerosis, cardiac remodeling, diastolic dysfunction, adipokins, apelin, RAAS, ACE2, angiotensin-(1-7), angiogenesis, microRNAs, gene polymorphisms, gut microbiota

Olmesartan improves left ventricular hypertrophy in patients with hypertension and type 2 diabetes with low angiotensin-(1-7) blood levels

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Pharmacotherapy

Session: Hypertension ePosters

Thumbnail

The blood levels of apelin and angiotensin-(1-7) and their interrelations with parameters of left ventricular remodeling in patients with hypertension and type 2 diabetes

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Ventricular Remodelling

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

Thumbnail

The relationship of apelin levels of the blood with left atrium size and its possible role in the development of atrial fibrillation in the patients with hypertension and type 2 diabetes

Event: EHRA 2019

Topic: Pathophysiology and Mechanisms

Session: Atrial Fibrillation - Pathophysiology and Mechanisms

Thumbnail

ESC 365 is supported by

logo Novo Nordisk